Cybin.
Canadian pharmaceutical company
- Reports this week
- 1
- Active events
- 0
- Connections
- 33
What's happening
One to three months ago
Gone quiet
No new reports in 90+ days-
Cybin is listed on the NASDAQ stock exchange, receiving buy rating coverage from TD Cowen, while Millennium Management increased its stake.Some support8 reports
-
Cybin develops treatments for GAD and receives European authorities approval for a Phase 3 trial, which will enroll participants in Australia.Some support2 reports1 development inside
-
Cybin's CYB004 program is targeting the treatment of GAD.Speculative1 report
-
Multinational clinical trials, including EMBRACE and PARADIGM, are enrolling participants across Europe and the US, supported by regulatory approvals.Some support3 reports1 development inside
-
Cybin approaches clinical trials across the United States.Speculative1 report
-
Cybin announced financing from Toronto on July 1, 2025.Speculative2 reports
-
Wall Street analysts agreed on better earnings predictions for Cybin.Some support1 report
-
Cybin is operational in the US, UK, Canada, Netherlands, and Ireland, utilizing LinkedIn and Instagram for updates, and its CEO attended a conference in Boston.Some support1 report
-
Cybin is operational in Ireland, following its successful product launches and regulatory approvals in various global markets.Some support1 report1 development inside
No events began in the chosen period. Widen it, or reset.
Around Cybin this week
News at the entities that move Cybin most-
FDA StructuralFDA conducted widespread seizures of prohibited food items and products across Pune, Nashik, Mumbai, Konkan, and Nanded.Moves Cybin
-
Nasdaq StructuralPraxis Precision Medicines and Relay Therapeutics were listed on the Nasdaq stock exchange on October 1, 2026.Moves Cybin
-
MarketBeat Mentioned togetherMarketBeat reported analyst ratings for Bath & Body Works and Carvana on October 1, 2026.Moves Cybin
-
Instagram OperationalDeacon Phillippe made his acting debut in a Netflix series and shared photos on Instagram.Moves Cybin
-
TD Cowen Mentioned togetherGoldman Sachs, TD Cowen, and Barclays cited valuation and growth concerns, leading to downgrades on July 25, 2026.Moves Cybin
-
Netherlands Shared contextTomTom, a location technology company, is based in the Netherlands.Moves Cybin
Connections
The 12 strongest of 33, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
Cybin is formally listed on the Nasdaq stock exchange.
-
Thermo Fisher Scientific (Netherlands) Structural
Cybin relies on Thermo Fisher Scientific for manufacturing and clinical supply services for its products.
-
FDA Structural
Cybin seeks and receives regulatory designations and approvals from the FDA.
-
Paradigm Structural
Cybin operates the Paradigm program, which is defined as a multinational initiative of Cybin.
-
Embrace Operational
Cybin is conducting the clinical study named EMBRACE.
-
TD Cowen Mentioned together
TD Cowen provides financial coverage and rating updates for Cybin.
-
MarketBeat Mentioned together
MarketBeat provides consensus rating data and tracking information for the company Cybin.
-
Netherlands Shared context
Cybin is reported to be operational within the Netherlands.
Show all 12 connections
-
Millennium Management Transactional
Millennium Management increased its financial stake in Cybin stock.
-
Instagram Operational
Cybin actively uses Instagram as a communication channel for updates and monitoring.
-
Toronto Shared context
Cybin is headquartered and operates within the city of Toronto.
-
Ireland Shared context
Cybin is reported to be operational within the geographical and regulatory context of Ireland.
History
Events by the month they beganJune 2026
10 events- Eric So was announced as the Co-Founder and President of Cybin in a news release issued from Toronto.
- Cybin is listed on the NASDAQ stock exchange, receiving buy rating coverage from TD Cowen, while Millennium Management increased its stake.
- Cybin develops treatments for GAD and receives European authorities approval for a Phase 3 trial, which will enroll participants in Australia.
- Cybin's CYB004 program is targeting the treatment of GAD.
- Multinational clinical trials, including EMBRACE and PARADIGM, are enrolling participants across Europe and the US, supported by regulatory approvals.
- Cybin approaches clinical trials across the United States.
- Cybin announced financing from Toronto on July 1, 2025.
- Wall Street analysts agreed on better earnings predictions for Cybin.
- Cybin is operational in the US, UK, Canada, Netherlands, and Ireland, utilizing LinkedIn and Instagram for updates, and its CEO attended a conference in Boston.
- Cybin is operational in Ireland, following its successful product launches and regulatory approvals in various global markets.